ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,564Medicare Part D Prescriptions Filled, Including Refills

Rank: 314 out of 1454

$537K Total Retail Price of All Prescriptions

Rank: 388 out of 1454

559 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 559 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 559 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 8,630 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LISINOPRIL 594 503 1 4
OMEPRAZOLE 486 352 2 3
SIMVASTATIN 403 307 3 1
WARFARIN SODIUM 344 344 4 17
HYDROCHLOROTHIAZIDE 301 258 5 9
LEVOTHYROXINE SODIUM 297 250 6 5
AMLODIPINE BESYLATE 264 243 7 2
METFORMIN HCL 247 180 8 8
FUROSEMIDE 235 208 9 6
NAMENDA 205 205 10 48
METOPROLOL TARTRATE 176 149 11 10
RANITIDINE HCL 168 119 12 43
METOPROLOL SUCCINATE 157 133 13 13
CITALOPRAM HBR 155 137 14 21
FLUTICASONE PROPIONATE 139 117 15 30
SERTRALINE HCL 127 107 16 26
TRAMADOL HCL 125 80 17 20
NEXIUM 120 84 18 23
CYCLOBENZAPRINE HCL 120 58 R 18 59
TAMSULOSIN HCL 116 112 20 34
HYDROCODONE-ACETAMINOPHEN 111 66 S3 21 7
POTASSIUM CHLORIDE 111 102 21 15
DONEPEZIL HCL 106 106 23 29
ATENOLOL 106 94 23 18
SYNTHROID 105 103 25 25
POLYETHYLENE GLYCOL 3350 100 99 26 61
ADVAIR DISKUS 100 74 26 47
AMITRIPTYLINE HCL 99 51 R 28 71
LOVASTATIN 90 80 29 39
GABAPENTIN 88 68 30 16
ALLOPURINOL 80 69 31 28
ISOSORBIDE MONONITRATE ER 79 79 32 46
LANTUS 79 78 32 51
LOSARTAN POTASSIUM 74 74 34 14
AZITHROMYCIN 73 50 35 42
PROAIR HFA 70 48 36 56
ACTOS 69 52 37 90
RESTASIS 68 68 38 267
SPIRIVA 64 60 39 52
GLIMEPIRIDE 64 40 39 33
ALENDRONATE SODIUM 61 61 41 35
MIRTAZAPINE 61 49 41 53
TRAZODONE HCL 60 59 43 50
ZOLPIDEM TARTRATE 60 32 43 19
CELEBREX 59 42 45 81
ATORVASTATIN CALCIUM 58 58 46 11
ROPINIROLE HCL 56 45 47 96
PAROXETINE HCL 53 53 48 73
SPIRONOLACTONE 51 51 49 63
PLAVIX 50 50 50 45
GLIPIZIDE XL 50 39 50 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.